US3404069A - Method for measuring the glucose content of blood serum - Google Patents

Method for measuring the glucose content of blood serum Download PDF

Info

Publication number
US3404069A
US3404069A US438772A US43877265A US3404069A US 3404069 A US3404069 A US 3404069A US 438772 A US438772 A US 438772A US 43877265 A US43877265 A US 43877265A US 3404069 A US3404069 A US 3404069A
Authority
US
United States
Prior art keywords
iodine
glucose
blood serum
color
measuring
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US438772A
Inventor
Arnold G Ware
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioconsultants Inc
Original Assignee
Bioconsultants Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioconsultants Inc filed Critical Bioconsultants Inc
Priority to US438772A priority Critical patent/US3404069A/en
Application granted granted Critical
Publication of US3404069A publication Critical patent/US3404069A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/54Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving glucose or galactose
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/904Oxidation - reduction indicators
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/14Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333Saccharide [e.g., DNA, etc.]
    • Y10T436/144444Glucose

Definitions

  • This invention relates to a method for the analytical determination of the glucose content of blood serum or plasma.
  • a previously published process for determination of glucose in blood serum consists in adding to the serum sample a glucose oxidase, which in a properly buffered solution, breaks the glucose down to gluconic acid and hydrogen peroxide. Potassium iodide is then added to the mixture, and free iodine and potassium tri-iodide are produced, using ammonium molybdate as a catalyst. The iodine color is then measured by comparison with known color standards.
  • the sample is pre-treated with a small amount of iodine for a short period prior to adding glucose oxidase.
  • This iodine reacts with any reducing agent present and the result of this reaction may be determined easily by measuring the iodine color which remains.
  • This measurement also includes any other interfering colored or turbid substances present in the sample such as bilirubin, hemoglobin, lipid or protein.
  • the glucose oxidase is added to release iodine, and the increase in color, which is directly proportional to the glucose, may be easily and accurately measured by visual or photometric means.
  • 0.05 ml. of the blood serum sample was treated with a standardized reagent containing potassium iodide, buffering salts to maintain the pH at ap proximate neutrality, and iodine.
  • a reagent solution containing 1 gram by weight of potassium iodide, 0.002 gram of free iodine, 2 grams by weight of a buffer salt (K HPO /KH PO to maintain the pH at 6.3 and 0.1 gram of ammonium molybdate for "Ice each ml. of aqueous solution was added to the sample. The mixture was allowed to incubate for 5 minutes, and the color measured by a photometer.
  • the color of the iodine in the solutions of the above described procedure may be intensified by as much as three times, by the addition of about 0.04 percent polyvinylpyrrolidone to the reagent solution specified above.
  • the advantages of this modification are that a smaller sample, 0.02 ml. of blood serum, suffices for the analysis, the accuracy of analysis is improved, and the conformance to Beers law is promoted. An excess of polyvinylpyrrolidone over the specified 0.04 percent does not improve the color intensification; and less than 0.04 percent results in a decreased intensification of color.
  • This liberation of iodine reaction can also be used to measure the glucose in other biological liquids, by making sure that the iodine present during the pretreatment is sufiicient to oxidize all the reducing agents present. In other words, iodine color should remain after the pretreatment.
  • the procedures as described above for blood serum may then be applied to the other biological liquids to obtain the glucose content.
  • the advantages will be apparent from the above description.
  • the blood serum may be accurately analyzed by my improved method, without the necessity of using laborious steps to remove the proteins and other interfering ingredients before applying the steps of the colori metric method above described.
  • the method for the analysis of blood serum for the determination of the concentration of glucose in biological fluids comprising the steps of first adding to said serum a small but effective amount of free iodine, whereby to oxidize free reducing agents in said serum; measuring the color concentration after said oxidation reaction is completed; then adding an oxidase reagent comprising buttered glucose oxidase, potassium iodide, and catalyst ammonium molybdate, and measuring the increase in color concentration over the first color measurement.
  • the method for the analysis of blood serum for the determination of the concentration of glucose in biological fluids comprising the steps of first adding to said serum a reagent comprising buffering salts, potassium iodide, catalyst ammonium molybdate, and a small but effective amount of iodine whereby to oxidize free reducing agents in said serum; measuring the color of the resulting liquid after the reaction has been completed; then adding glucose oxidase; and measuring the increase in color concentration over the first color measurement.
  • a reagent solution effective for liberation of free iodine by glucose oxidase comprising glucose oxidase containing a proportion of a buffer salt to maintain the pH of the reagent solution at 6.3, potassium iodide, a catalyst, and about 0.04 percent by weight of polyvinylpyrrolidone.

Description

United-States Patent 3,404,069 METHOD FOR MEASURING THE GLUCOSE CONTENT OF BLOOD SERUM Arnold G. Ware, South Pasadena, Calif., assignor to Bioconsultants, Inc., Glendale, Calif., a corporation of California No Drawing. Filed Mar. 10, 1965, Ser. No. 438,772
6 Claims. (Cl. 195-1035) ABSTRACT OF THE DISCLOSURE Method for the determination of glucose in blood serum, which may be used without deproteinizing said serum sample, comprising adding a small amount of iodine to the serum to oxidize free reducing agents in said serum, measuring the color, adding an oxidase reagent, and measuring the color change. PVP is used to intensify the colors thus produced.
This invention relates to a method for the analytical determination of the glucose content of blood serum or plasma.
A previously published process for determination of glucose in blood serum consists in adding to the serum sample a glucose oxidase, which in a properly buffered solution, breaks the glucose down to gluconic acid and hydrogen peroxide. Potassium iodide is then added to the mixture, and free iodine and potassium tri-iodide are produced, using ammonium molybdate as a catalyst. The iodine color is then measured by comparison with known color standards.
This process is described in Clinical Chemistry, Principles and Technics, by Henry, published by Hoeber Medical Division of Harper & Roe-Publishers, 1964, at pages 632-635. It is also described in a publication by Malmstadt and Hadjiioannou, in Anal. Chem. 34, page 452 (1962).
It has been found that this method or similar methods using glucose oxidase cannot be applied directly to blood serum because these specimens are complex in nature and do not act as does pure glucose. Serum contains reducing agents of various kinds which take up the free iodine produced, thus resulting in an erroneously low analysis for glucose content. The greater portion of these reducing agents can be removed by precipitating the proteins present with cadmium or zinc hydroxide. The protein-free solution is then used for the analysis.
I have discovered a simple procedure which prevents the interference from reducing agents and allows direct analysis on serum or other body fluids without the protein precipitation step. The sample is pre-treated with a small amount of iodine for a short period prior to adding glucose oxidase. This iodine reacts with any reducing agent present and the result of this reaction may be determined easily by measuring the iodine color which remains. This measurement also includes any other interfering colored or turbid substances present in the sample such as bilirubin, hemoglobin, lipid or protein. Following this pretreatment with iodine, the glucose oxidase is added to release iodine, and the increase in color, which is directly proportional to the glucose, may be easily and accurately measured by visual or photometric means.
As an example, 0.05 ml. of the blood serum sample Was treated with a standardized reagent containing potassium iodide, buffering salts to maintain the pH at ap proximate neutrality, and iodine. Five milliliters ml.) of a reagent solution containing 1 gram by weight of potassium iodide, 0.002 gram of free iodine, 2 grams by weight of a buffer salt (K HPO /KH PO to maintain the pH at 6.3 and 0.1 gram of ammonium molybdate for "Ice each ml. of aqueous solution was added to the sample. The mixture was allowed to incubate for 5 minutes, and the color measured by a photometer. Then 0.2 ml. of a concentrated solution of glucose oxidase were then added and incubated for ten minutes, following which the photometer reading for color concentration was again made. The increased concentration of yellow iodine color was then mathematically converted to concentration of glucose in the blood serum sample, using glucose comparison standards.
It has also been found that the color of the iodine in the solutions of the above described procedure may be intensified by as much as three times, by the addition of about 0.04 percent polyvinylpyrrolidone to the reagent solution specified above. The advantages of this modification are that a smaller sample, 0.02 ml. of blood serum, suffices for the analysis, the accuracy of analysis is improved, and the conformance to Beers law is promoted. An excess of polyvinylpyrrolidone over the specified 0.04 percent does not improve the color intensification; and less than 0.04 percent results in a decreased intensification of color.
This liberation of iodine reaction can also be used to measure the glucose in other biological liquids, by making sure that the iodine present during the pretreatment is sufiicient to oxidize all the reducing agents present. In other words, iodine color should remain after the pretreatment. The procedures as described above for blood serum may then be applied to the other biological liquids to obtain the glucose content.
The advantages will be apparent from the above description. The blood serum may be accurately analyzed by my improved method, without the necessity of using laborious steps to remove the proteins and other interfering ingredients before applying the steps of the colori metric method above described.
I claim:
1. The method for the analysis of blood serum for the determination of the concentration of glucose in biological fluids comprising the steps of first adding to said serum a small but effective amount of free iodine, whereby to oxidize free reducing agents in said serum; measuring the color concentration after said oxidation reaction is completed; then adding an oxidase reagent comprising buttered glucose oxidase, potassium iodide, and catalyst ammonium molybdate, and measuring the increase in color concentration over the first color measurement.
2. The method for the analysis of blood serum for the determination of the concentration of glucose in biological fluids comprising the steps of first adding to said serum a reagent comprising buffering salts, potassium iodide, catalyst ammonium molybdate, and a small but effective amount of iodine whereby to oxidize free reducing agents in said serum; measuring the color of the resulting liquid after the reaction has been completed; then adding glucose oxidase; and measuring the increase in color concentration over the first color measurement.
3. The method defined in claim 1, wherein the oxidase reagent contains about 0.04 percent by weight of polyvinylpyrrolidone.
4. The method defined in claim 2, wherein the reagent contains about 0.04 percent by weight of polyvinylpyrrolidone.
5. A reagent solution effective for liberation of free iodine by glucose oxidase comprising glucose oxidase containing a proportion of a buffer salt to maintain the pH of the reagent solution at 6.3, potassium iodide, a catalyst, and about 0.04 percent by weight of polyvinylpyrrolidone.
73,404,069 v 4 3 4. 6. A reagent solution efiective for liberation of free OTHER REFERENCE iodine by glucose oxidase Comprising wp gram of Pardue, H. L.: Analytical Chemistry, vol. 35, pp. 1240- potassium iodide, 0.002 gram of free 1od1ne, 2 grams 1243 (1963). of a buiTer salt (K HPO /KH PO to mamtam the P Runti, 0.: Chemical Abstracts, vol. 52, p. 12329i at 6.3, 0.1 gram of ammonium molybdate, and 0.04 gram 5 (1958) of polyvinylpyrrolidone, for each 100 ml. of aqueous solution.
References Cited MORRIS O. WOLK, Przmaly Examzner. UNITED STATES PATENTS E. A. KATZ, Assistant Examiner 2,850,359 9/1958 Worthington et a1. 23-230 w
US438772A 1965-03-10 1965-03-10 Method for measuring the glucose content of blood serum Expired - Lifetime US3404069A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US438772A US3404069A (en) 1965-03-10 1965-03-10 Method for measuring the glucose content of blood serum

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US438772A US3404069A (en) 1965-03-10 1965-03-10 Method for measuring the glucose content of blood serum

Publications (1)

Publication Number Publication Date
US3404069A true US3404069A (en) 1968-10-01

Family

ID=23741948

Family Applications (1)

Application Number Title Priority Date Filing Date
US438772A Expired - Lifetime US3404069A (en) 1965-03-10 1965-03-10 Method for measuring the glucose content of blood serum

Country Status (1)

Country Link
US (1) US3404069A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933593A (en) * 1971-02-22 1976-01-20 Beckman Instruments, Inc. Rate sensing batch analysis method
FR2372426A1 (en) * 1976-11-25 1978-06-23 Merck Patent Gmbh

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2850359A (en) * 1956-09-07 1958-09-02 Worthington Biochem Corp Testing unit and method of testing for glucose

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2850359A (en) * 1956-09-07 1958-09-02 Worthington Biochem Corp Testing unit and method of testing for glucose

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3933593A (en) * 1971-02-22 1976-01-20 Beckman Instruments, Inc. Rate sensing batch analysis method
FR2372426A1 (en) * 1976-11-25 1978-06-23 Merck Patent Gmbh
US4143080A (en) * 1976-11-25 1979-03-06 The Goodyear Tire & Rubber Company Method and reagent for the assay of hydroperoxide

Similar Documents

Publication Publication Date Title
Dutt et al. Determination of uric acid at the microgram level by a kinetic procedure based on a pseudo-induction period
Nickerson et al. Colorimetric estimation of lactose and its hydrolytic products
Foster et al. A single-reagent manual method for directly determining urea nitrogen in serum
Laurell et al. An enzymatic fluorometric micromethod for the determination of glycerol
SU542484A3 (en) Method for quantitative determination of substances capable of enzymatic oxidation in aqueous solution
FI97551B (en) Method of analysis, reagent composition and its use for the determination of glucose
Zaugg et al. Indirect determination of inorganic phosphate by atomic absorption spectrophotometric determination of molybdenum.
Levy et al. Microdetermination of polyvinylpyrrolidone in aqueous solution and in body fluids
Van Belle New and sensitive reaction for automatic determination of inorganic phosphate and its application to serum
FI81120B (en) FOERFARANDE FOER BESTAEMNING AV GLUKOS UR BIOLOGISKA VAETSKA SAMT REAGENSBLANDNING FOER TILLAEMPNING AV FOERFARANDET.
CA1198346A (en) Fluid analysis
CN108896750B (en) Preparation method and application of BSA-Au/Ag NCs/OPD/HRP proportional type fluorescence sensor
US3404069A (en) Method for measuring the glucose content of blood serum
Cox et al. The measurement of dehydroascorbic acid and diketogulonic acid in normal and diabetic plasma
Iwasaki et al. A New Microdetermination of Iodide by its Catalytic Reaction
Yarbro et al. Complexometric titration of urinary calcium and magnesium
US3649198A (en) Diagnostic method for the determination of uric acid in blood
SU416969A3 (en)
US3792044A (en) Method for determining glucose with o-toluidine reagent containing an arsenic compound
Gray Critical factors in the resorcinol reaction for the determination of fructose
Klein et al. Application of Fe (II)-5-pyridyl benzodiazepin-2-ones to the determination of serum iron and iron-binding capacity
JP3220378B2 (en) Method and reagent for quantification of total protein
Giragossintz et al. The micro determination of blood sugar by ceric sulfate titration
Wahba A simple micro colorimetric method for the determination of lactose in milk
US5055398A (en) Process for measuring the concentration of a component in body fluid such as urine or blood